{"id":76744,"date":"2018-03-11T12:43:38","date_gmt":"2018-03-11T19:43:38","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2018\/03\/placenta-makes-100-years-old-the-new-60-fox-business-mornings-with-maria"},"modified":"2018-03-12T12:03:36","modified_gmt":"2018-03-12T19:03:36","slug":"placenta-makes-100-years-old-the-new-60-fox-business-mornings-with-maria","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2018\/03\/placenta-makes-100-years-old-the-new-60-fox-business-mornings-with-maria","title":{"rendered":"Placenta makes 100-years old the new 60 \u2014 Fox Business Mornings With Maria"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/jkQV3gUua_8?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>Celularity, a leading U.S. biotechnology company, is seizing on an opportunity to use cells to target diseases. The CEO, Dr. Robert Hariri, says placenta can be used to augment longevity and immunity. <a href=\"\/redirect?q=https%3A%2F%2Fwww.celularity.com&v=jkQV3gUua_8&event=video_description&redir_token=QKlLB38bGZR8iE-br1upaZX8KUh8MTUyMDg4MzgwNEAxNTIwNzk3NDA0\" class=\"\" data-target-new-window=\"True\" data-sessionlink=\"itct=CDQQ6TgYACITCJDPs-iD5dkCFQbRrgodiQMGjCj4HUj_17mp4LuFoo4B\" data-url=\"\/redirect?q=https%3A%2F%2Fwww.celularity.com&v=jkQV3gUua_8&event=video_description&redir_token=QKlLB38bGZR8iE-br1upaZX8KUh8MTUyMDg4MzgwNEAxNTIwNzk3NDA0\" target=\"_blank\" rel=\"nofollow noopener\"><a href=\"https:\/\/www.celularity.com\">https:\/\/www.celularity.com<\/a><\/a><\/p>\n<p>Celularity\u2019s Massively Transformative Purpose (MTP) is to harness the power of the living cell to augment biology, immunity and longevity.<\/p>\n<p><a href=\"\/redirect?q=http%3A%2F%2Fwww.foxbusiness.com%2Ffeatures%2F2018%2F02%2F15%2Fbiotech-breakthrough-placenta-makes-100-years-old-new-60-research-finds.html&v=jkQV3gUua_8&event=video_description&redir_token=QKlLB38bGZR8iE-br1upaZX8KUh8MTUyMDg4MzgwNEAxNTIwNzk3NDA0\" class=\"\" data-target-new-window=\"True\" data-sessionlink=\"itct=CDQQ6TgYACITCJDPs-iD5dkCFQbRrgodiQMGjCj4HUj_17mp4LuFoo4B\" data-url=\"\/redirect?q=http%3A%2F%2Fwww.foxbusiness.com%2Ffeatures%2F2018%2F02%2F15%2Fbiotech-breakthrough-placenta-makes-100-years-old-new-60-research-finds.html&v=jkQV3gUua_8&event=video_description&redir_token=QKlLB38bGZR8iE-br1upaZX8KUh8MTUyMDg4MzgwNEAxNTIwNzk3NDA0\" target=\"_blank\" rel=\"nofollow noopener\"><a href=\"http:\/\/\/redirect?q=http%3A%2F%2Fwww.foxbusiness.com%2Ffeatures%2F2018%2F02%2F15%2Fbiotech-breakthrough-placenta-makes-100-years-old-new-60-research-finds.html&v=jkQV3gUua_8&event=video_description&redir_token=QKlLB38bGZR8iE-br1upaZX8KUh8MTUyMDg4MzgwNEAxNTIwNzk3NDA0\">\/redirect?q=http%3A%2F%2Fwww.foxbusiness.com%2Ffeatures%2F2018%2F02%2F15%2Fbiotech-breakthrough-placenta-makes-100-years-old-new-60-research-finds.html&amp;v=jkQV3gUua_8&amp;event=video_description&amp;redir_token=QKlLB38bGZR8iE-br1upaZX8KUh8MTUyMDg4MzgwNEAxNTIwNzk3NDA0<\/a><\/a><\/p>\n<p><!-- Link: <a href=\"https:\/\/www.youtube.com\/watch?v=jkQV3gUua_8&feature=share\">https:\/\/www.youtube.com\/watch?v=jkQV3gUua_8&feature=share<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Celularity, a leading U.S. biotechnology company, is seizing on an opportunity to use cells to target diseases. The CEO, Dr. Robert Hariri, says placenta can be used to augment longevity and immunity. https:\/\/www.celularity.com Celularity\u2019s Massively Transformative Purpose (MTP) is to harness the power of the living cell to augment biology, immunity and longevity. \/redirect?q=http%3A%2F%2Fwww.foxbusiness.com%2Ffeatures%2F2018%2F02%2F15%2Fbiotech-breakthrough-placenta-makes-100-years-old-new-60-research-finds.html&amp;v=jkQV3gUua_8&amp;event=video_description&amp;redir_token=QKlLB38bGZR8iE-br1upaZX8KUh8MTUyMDg4MzgwNEAxNTIwNzk3NDA0<\/p>\n","protected":false},"author":432,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,269],"tags":[],"class_list":["post-76744","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/76744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/432"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=76744"}],"version-history":[{"count":1,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/76744\/revisions"}],"predecessor-version":[{"id":76765,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/76744\/revisions\/76765"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=76744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=76744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=76744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}